Advanced Bio-Curcumin with Ginger & Turmerones

Kr  327

Tilgjengelighet: På lager

Bli den første som omtaler dette produktet

Oversikt

Advanced Bio-Curcumin® with Ginger & Turmerones 30 softgels

Item Catalog Number: 01808

URTENS EGENSKAPER OG VIRKNING
Gurkemeie har en bitter, skarp og aromatisk smak, og virker avkjølende og stimulerende. Urten retter opp metabolismen i leveren og virker galledrivende (kan øke utskillelsen av galle med opp til 130 % og påvirker gallens kvalitet i gunstig retning), virker kolesterolsenkende (senker utskillingen av cholesterin fra leveren og øker utskillelsen via tarmsystemet), betennelseshemmende (øker innholdet av kortisol i blodet og hemmer prostaglandin-syntesen), smertelindrende, blodrensende, blodsukkersenkende, blodfortynnende, blodtrykksenkende, blodårestyrkende, astringerende, sårhelende, sopphemmende, bakteriehemmende (virker bl.a. på hemolyttiske streptokokker, stafylokokker og enterokokker), leverbeskyttende (i dyreforsøk vist å beskytte mot skadelige virkninger av tetraklorkarboner), cytotoksisk mot kreftceller, hemmer veksten av kreftsvulster, beskytter mot kreft, antioksidant, antikoagulerende, beskytter mot åreforkalkning, appetittstimulerende, stimulerer fordøyelsesenzymene, fordøyelsesfremmende, magestyrkende (øker slimdannelsen i magesekken og er dermed magesårforebyggende), urindrivende, menstruasjonsdrivende, beskytter mot sammenklumping av blodplater, bedrer blodflyten i arteriene, styrker blodårene og beskytter mot grå stær. Gurkemeie er eksperimentelt vist å kunne hemme formeringen av HIV-viruset.

URTEN KAN BRUKES VED FØLGENDE HELSEPLAGER / SYKDOMMER
Gurkemeie hjelper til å stabilisere kroppens mikroflora, bl.a. ved å hemme overvekst av gjærsopp. Urten kan brukes ved høyt kolesterol, gulsott, gallestein, kolecystitt (betennelse i galleblæren), åreforkalkning, blodpropp, hjerneslag, kreft, magekatarr, magesår, dårlig appetitt, dyspepsi (dårlig fordøyelse), hypoklorhydri (mangel på saltsyre i magen), kvalme, kolikk, raping, mye tarmgass, magesår, diaré, akutte eller kroniske betennelser i ledd, muskler og andre organ, lumbago (vondt i korsryggen), artrose, revmatoid artritt, gikt, astma, eksem, psoriasis, soppinfeksjoner, fotsopp, menstruasjonskramper og smertefull menstruasjon. Utvortes kan man bruke gurkemeie som et omslag ved fotsopp, skrammer, eksem, psoriasis, forstuinger, opphovninger og skader.

Denne teksten er hentet og brukt med tillatelse fra Urtekilden - www.rolv.no

Curcumin is an active compound derived from the Indian spice turmeric. It has been widely acclaimed for its diverse health-promoting effects on nearly every organ system in the body,1-6 including its support for the body’s natural inflammatory response system.7 But most curcumin is neither absorbed well nor retained well in the blood—posing a challenge to those who wish to maximize its benefits.8

Life Extension® took the lead in resolving this issue several years ago by introducing Super Bio-Curcumin® containing BCM-95®, a patented, bioenhanced preparation of curcumin that has been shown to reach up to seven times higher concentration in the blood than standard curcumin.8

Now, an exciting next generation curcumin formula has become available. Advanced Bio-Curcumin® with Ginger & Turmerones provides additional compounds that further boost absorption of curcumin’s highly beneficial phytonutrients.9,10

In addition to BCM-95®, this new curcumin formula contains:

Turmerones: After curcumin is extracted from turmeric, what remains is turmeric oil rich in compounds called turmerones.11,12 Combining BCM-95® with a high content of turmerones provides health consumers with more beneficial turmeric compounds that further multiply absorption.9 Scientists have shown that these potent turmerones not only support curcumin absorption, but significantly increase the amount of curcumin inside the cell as well.9
Ginger: Curcumin and ginger are close botanical relatives. Research demonstrates that they have overlapping and complementary health benefits,13 and scientists are focusing on the therapeutic effects of combining these two plants.14,15 Advanced Bio-Curcumin® with Ginger & Turmerones provides a supercritical extract of ginger standardized to the greatest concentration of ginger compounds—including beneficial gingerols and shogaols.
Phospholipids: This new curcumin formula also contains phospholipids, a type of emulsifying molecule known to greatly enhance absorption of poorly soluble active compounds.10
The enhanced bioavailability and potency of Advanced Bio-Curcumin® with Ginger & Turmerones is superior to conventional curcumin supplements. This product represents the most powerful and cost-effective way to supplement with—and receive the full benefits of—this very critical nutrient.

References
1. Adv Exp Med Biol. 2007;595:197-212.
2. Biofactors. 2013 Jan-Feb;39(1):2-13.
3. Clin Exp Pharmacol Physiol. 2012 Mar;39(3):283-99.
4. Adv Exp Med Biol. 2007;595:1-75.
5. Trends Pharmacol Sci. 2009 Feb;30(2):85-94.
6. Curr Drug Targets. 2011 Mar 1;12(3):332-47.
7. J Clin Immunol. 2007 Jan;27(1):19-35.
8. Indian J Pharm Sci. 2008 Jul-Aug;70(4):445-9.
9. J Med Food. 2012 Mar;15(3):242-52.
10. Cancer Chemother Pharmacol. 2007;60:171-7.
11. J Agric Food Chem. 1999 Oct;47(10):4297-300.
12. Z Naturforsch C. 2001 Jan-Feb;56(1-2):40-4.
13. Osteoarth Cartilage. 2003 Nov;11(11):783-9.
14. Wound Repair Regen. 2009 May-Jun;17(3):360-6.
15. Available at: http://www.umassmed.edu/hema_oncology/ MDSInfo/curcuminandgingerol.aspx . Accessed September 25, 2013.

 

Detaljer

Bio-Enhanced TURMERIC Compounds Block Multiple Inflammatory Pathways

Tradisjonell anvendelse av gurkemeie

Gurkemeiens lange og fargerike historie i mange asiatiske kulturer omfatter århundrers bruk som krydder, konserveringsmiddel for mat, medisin og fargestoff. Blant mange bruksområder, blir gurkemeie anvendt i ayurvedisk medisinsk tradisjon til behandling av leversykdommer, urinveisplager og dårlig fordøyelse. Urten blir påført utvortes som salve eller omslag for behandling av betennelser, insektstikk, ringorm, forstuinger, smertefulle ledd, sår, blødninger, skader og ulike hudproblemer.

Gurkemeie er en viktig fargeplante som gir en briljant gullgul fargenyanse som er brukt til å sette farge på mat, papir, tre, kosmetikk og ferdigmat. Til og med de gylne klesplaggene til buddhistmunkene kunne få sin farge av gurkemeie. Mange steder i Sørøst-Asia brukes gurkemeie også til sminke, både til hverdags og ved høytidelige anledninger som bryllup. I tradisjonelle bryllupsseremonier i det nordlige India blir gurkemeie påført brud og brudgom for å gi beskyttelse mot "det onde øye". I Nepal smører gjeterne "det tredje øyet" (midt på pannen) med en pasta med gurkemeie før de går til arbeidet høyt oppe i fjellene for å gi beskyttelse, velsignelse og suksess. I andre folkloristiske tradisjoner blir gurkemeie ansett som et symbol på velstand, og blir brukt til rensing.

I tradisjonell kinesisk medisin blir gurkemeie brukt til behandling av betennelser, smertefull menstruasjon, urinveisplager, leverforstyrrelser og skader. I Thailand er gurkemeie en av de viktigste folkemedisinene og har vært anvendt til å behandle svimmelhet, gonoré og magesår, og som et appetittstimulerende, fordøyelsesfremmende, astringerende (sammentrekkende) og stoppende middel.

Gurkemeie var også kjent blant oldtidens vestlige medisinere, og den greske urtelegen Dioskorides nevnte urten i sine skrifter fra det første århundret e.Kr. Blant de urtene som er klassifisert som krydder, er gurkemeie i våre dager en av de best utforskede med tanke på farmakologisk virkning.

Gurkemeie er rik på antioksidanter

Lenge før vi hadde hørt om antioksidanter og visste hvordan disse beskytter oss mot sykdom, hadde folk sørget for å opprettholde god helse ved å krydre maten med det gyllengule krydderet gurkemeie. Gurkemeie har i generasjoner vært brukt som et vanlig middel i tradisjonell indisk (ayurvedisk) medisin og andre medisinske systemer i Asia til behandling av artritt og andre betennelsestilstander. Nå har vitenskapen identifisert et kraftig antioksidativt stoff i gurkemeie som både har mange medisinske egenskaper og som også har verdi gjennom sin tradisjonelle bruk til matkonservering i varme tropiske land.

Hva forskningen har vist

Den kliniske forskningen som er utført med gurkemeie har til nå vært relativt begrenset, men studier som er gjennomført har gitt store forventinger både hos forskere og terapeuter. Blant de mange vitenskapelig dokumenterte virkeområdene for gurkemeie og urtens innholdsstoffer, er den betennelseshemmende, krefthemmende, leverbeskyttende, galledrivende og antivirale virkningen, samt at gurkemeie er en kraftig antioksidant. I forskning som pågår, undersøker man det kliniske potensialet til stoffet curcumin til beskyttelse mot og behandling av kreft, AIDS, for høyt kolesterol, verkesår, galleblære- og leversykdommer, og betennelsessykdommer som artritt.

Det meste av forskningen som til nå er gjort på gurkemeie og curcumin er utført i India. Noen av de mest interessante av disse studiene har undersøkt gurkemeie som et betennelseshemmende middel, og forskningen har gitt vitenskapelige bevis for denne viktige ayurvediske urtens effekt. I andre studier har gurkemeie vist en overbevisende kreftbeskyttende virkning, i tillegg til å senke kolesterolet og nivåene av blodlipid peroksider hos friske personer.

Innholdsstoffet curcumin og dets virkning

Gurkemeie fanget oppmerksomheten til vestlige forskere på 1970-tallet, da forskning kastet nytt lys på den medisinske verdien av de stoffene i gurkemeie som kalles curcuminoider. Denne viktige gruppen av antioksidante og betennelseshemmende innholdsstoffer gir også gurkemeie den skarpe guloransje fargen. Mye av forskningen på gurkemeie har vært knyttet til et spesielt curcuminoid kjent som curcumin. Som antioksidant er curcumin anslått å være 30 ganger så kraftig som zingeron, en antioksidantforbindelse i ingefær (Zingiber officinale).

Betennelseshemmende effekt

Kliniske studier og laboratorieundersøkelser som har vurdert curcuminets virkning mot betennelser, har vist at stoffet er like effektivt som kortison og ikkesteroide betennelseshemmende medisiner (NSAID-midler), som curcumin ble testet mot. Disse kraftfulle syntetiske medisinene er standard behandling for å redusere smerter, stivhet og betennelser ved artritt, men kan gi ulike alvorlige bivirkninger, som sår i fordøyelseskanalen, blødninger, anemi, utslett, væskeopphopning, leverproblemer og nyreskader. Ved en betennelse øker aminotransferasene ASAT og ALAT i blodet. Disse enzymene inntar sine normalverdier igjen ved inntak av curcumin. Effekten skyldes sannsynligvis curcuminenes innvirkning på biosyntesen av prostaglandin.

Den betennelseshemmende virkningen av gurkemeie er ikke bare knyttet til curcuminet, men også til den eteriske oljen i urten, noe som er vist i en rekke eksperimentelle modeller. Farmakologisk studier på dyr har vist at 40-85 % av det curcuminet som inntas gjennom munnen passerer uendret gjennom fordøyelseskanalen. Mesteparten av flavonoidene som blir absorbert blir omdannet i tarmens slimhinner og i leveren. På grunn av det lave opptaket, blir curcumin ofte anbefalt inntatt sammen med bromelain (et stoff i ananas) for å øke absorpsjonen og den betennelseshemmende virkningen.

Antibiotisk virkning

Indiske healere anbefaler gurkemeie for å bli kvitt innvollsparasitter, særlig nematoder. Dette smakfulle krydderet inneholder fire forbindelser med antiparasittisk virkning. Hver for seg har disse forbindelsene ingen virkning, men når de er blandet sammen har de kraftige ormedrepende egenskaper.

Den eteriske oljen fra gurkemeie er vist å kunne hemme veksten av en rekke mikroorganismer, bl.a. Clostridium, Staphylococcus, Streptococcus, Bacillus, Entamoeba histolytica og en rekke sykdomsfremkallende sopper. Virkningen av den eteriske oljen fra gurkemeie var i ulike studier sammenlignbar med de som ble oppnådd med kortison og fenylbutazon. Mens det er knyttet betydelig giftighet til både fenylbutazon og kortison, er gurkemeie ikke giftig i det hele tatt. Gurkemeie har vært brukt på en trygg måte som krydder i lange tider, og innholdsstoffet curcumin har ikke gitt bivirkninger i de kliniske studiene som er utført.

Gurkemeie og kreft

Curcumin kan beskytte mot genetiske mutasjoner som kan føre til kreft. I laboratoriestudier har både gurkemeie og curcumin vist en kraftig antikreftvirkning under alle stadier av utviklingen av kreft. I tallrike studier har curcumin redusert antallet og størrelsen på svulster hos dyr med eksperimentelt frambrakt kreft, inklusive hudkreft, endetarmskreft og magekreft.

Gurkemeie og curcumin har også vist lovende resultater i kliniske studier på mennesker med kreft og forstadier til kreft. Både i in vitro og in vivo studier har gurkemeie og curcumin vist betydelig krefthemmende virkning ved eksponering for en rekke kjemiske kreftfremkallende stoffer, som f.eks. tobakksrøyk. I tillegg til å hemme utviklingen av kreft, finnes det data fra mange studier som antyder at curcumin også kan fremme tilbakegangen av kreft.

Den beskyttende virkningen av gurkemeie og derivater av urten kan bare delvis forklares gjennom en direkte antioksidantvirkning. Urten hemmer også dannelsen av nitrosaminer, styrker kroppens eget antioksidantsystem, øker mengdene med glutation og andre ikkeprotein-sulfhydryler, og virker direkte på en rekke enzymer og genetisk materiale.

Gurkemeie som antioksidant

Nåværende forskning antyder at antioksidantvirkningen av curcuminoidene (inkl. curcumin) er den viktigste bidragsyteren til gurkemeiens helsebeskyttende virkning. Antioksidantvirkningen til curcumin er sammenlignbar med andre antioksidanter som vitamin C og E. Tallrike studier, inkl. forsøk med mennesker, har vist at curcumin kan bekjempe frie radikaler og beskytte mot dannelsen av oksidanter i kroppen. Gurkemeie synes også å fremme aktiviteten til kroppens eget antioksidantsystem. På grunn av den gule fargen og den beskyttende virkningen mot fettoksidering, blir curcumin brukt i smør, margarin, ost og andre matvarer.

Gunstig virkning på hjertekarsystemet

Virkningen av gurkemeie og curcumin på hjertekarsystemet omfatter både en senkning av kolesterolnivåene og at urten hindrer blodplatene i å klebe seg sammen slik at blodet blir "tykt". For mye sammenklebing av blodplater er involvert i en rekke sykdommer, bl.a. åreforkalkning, hjertesykdommer, astma og betennelsestilstander.

Virkning på leveren

Curcumin har ved leverskader vist lignende leverbeskyttende virkning som glycyrrhizin fra lakrisrot (Glycyrrhiza glabra) og silymarin fra frøene av mariatistel (Silybum marianum). Denne beskyttelsen er nok stort sett et resultat av curcuminets kraftige antioksidantvirkning. Finske og amerikanske forskere har gjort forsøk med rotter og funnet ut at en substans i gurkemeien hindrer leverskadene som forårsakes av overdrevent alkoholinntak.

Gurkemeie motvirker gallestein

Curcumin er et aktivt galledrivende stoff som øker utskillelsen av gallesyre med omkring 100 %. I tillegg til å øke gallens sekresjon av gallesalter, kolesterol og bilirubin, øker curcumin også oppløseligheten til gallen. Dette kan ha betydning som beskyttelse mot dannelse av gallestein.

Det er sagt at det er færre tilfeller av gallestein i India, noe man tror skyldes inntak av gurkemeie i maten. Gurkemeie kan nemlig være nyttig både til å forebygge og behandle gallestein. I flere forsøk med dyr der man eksperimentelt har framkalt gallestein, har man vist at de dyrene som ble satt på diett med mye curcumin allerede i løpet av fem uker hadde fått forminsket tendens til gallesteindannelse med 45 %. Etter 10 uker hadde de curcuminbehandlede dyrene opptil 80 % færre gallestein enn de ubehandlede. Curcumin forbedrer oppløseligheten av gallen, og det betyr at det ikke så lett utfelles stein og krystaller i gallegangen. Ved gallestein kan man spise mye karriretter og kanskje tilsette ekstra gurkemeie i maten. Lite, men ofte, er i dette tilfellet bedre enn korte og intensive kurer med høyt inntak av gurkemeie. Husk imidlertid at hvis du har gallestein som blokkerer gallegangen, må du ikke innta gurkemeie.

Godt for fordøyelsen

Gurkemeie og urtens ulike innholdsstoffer kan framvise en rekke gunstige virkninger på fordøyelsessystemet. Lang tids bruk av gurkemeie mot tarmgassproduksjon har fått betydelig støtte gjennom forskning. Stoffet natriumcurcuminat er vist å kunne dempe tarmkramper, og andre komponenter i gurkemeie øker utskillingen av fordøyelsesenzymer. Gurkemeie og curcumin øker innholdet av slimstoffer i magen og beskytter på den måten mot sårdannelse som kan være indusert av stress, alkohol eller andre påvirkninger. I svært høye doser kan imidlertid gurkemeie og curcumin virke motsatt og forårsake sårdannelse.

I en spennende thailandsk undersøkelse har leger vist at 250 mg gurkemeie i kapselform, tatt tre ganger om dagen, var ca. halvparten så effektivt som annen magesårhemmende medisin ved smerter i magen som skyldtes irritasjon av mageslimhinnen. Selv om det er en noe svakere virkning av gurkemeie enn av vanlige magesårmedisiner, er fordelen for de fattige i Østen at gurkemeie koster bare en brøkdel av vanlig magesårmedisin.

Gurkemeie er godkjent av tyske helsemyndigheter som behandling for fordøyelsesproblemer, primært fordi den stimulerer utskillelsen av galle fra galleblæren.

Klinisk anvendelse og dosering

Gurkemeie blir først og fremst brukt ved akutte eller kroniske betennelser i ledd, muskler og andre organ, f.eks. ved leddrevmatisme, artrose, lumbago (vondt i korsryggen), kolecystitt (betennelse i galleblæren) med eller uten gallestein, osv. Urten kan også brukes som krydder for å stimulere appetitten og produksjonen av fordøyelsesvæsker. Videre brukes gurkemeie og curcumin klinisk til beskyttelse mot og behandling av kreft, til behandling av betennelser, arteriosklerose, leverplager, gallestein og irritabel tykktarm syndrom. Selv om det trengs flere studier på mennesker når det gjelder bruk av gurkemeie eller curcumin ved kreft, synes det å være berettiget å anbefale urten som beskyttelse mot kreft og som støtte ved annen kreftbehandling. Gurkemeie har vært mye brukt i ayurvedisk medisin, både lokalt utvortes, og innvortes til behandling av forstrekninger og betennelser. Effekten av slik bruk er erfart både gjennom eksperimentelle studier og ved klinisk anvendelse.

Da både den eteriske oljen og curcuminoidene i gurkemeie er lite løselige i vann, blir urtete av gurkemeie sjelden brukt terapeutisk. I stedet bruker man alkoholbaserte flytende ekstrakter eller tinkturer av urten, eller pulver i kapselform. Normal daglig dose av gurkemeie er 1-3 g malt gurkemeie 2-3 ganger daglig, som best inntas sammen med et måltid og da gjerne blandet i maten som krydder. Dosen kan gradvis økes opp til maks. 20 g om dagen for å oppnå ønsket effekt. Av en 1:5 tinktur kan man innta inntil 10 ml daglig. Etter en måned bør man gjøre opphold i noen dager for å se om plagene kommer tilbake. Ved behov kan man seinere fortsette behandlingen i ytterligere en måned, og så videre.

Alternativt kan man bruke preparater med gurkemeie. Av ren curcumin er anbefalt dosering for terapeutisk bruk 400-600 mg tre ganger daglig. Gurkemeie-ekstrakter er vanligvis standardisert til 95 % curcuminoider. Stoffet piperin (som finnes i pepper) øker opptaket i kroppen av curcuminoiden, så det kan være lurt å innta litt svart pepper sammen med gurkemeie.

Denne teksten er hentet og brukt med tillatelse fra Urtekilden - www.rolv.no

By Michael Downey

Bio-Enhanced TURMERIC Compounds Block Multiple Inflammatory Pathways  

Millions of Americans suffer from chronic pain caused by inflammation, while millions more suffer diseases caused by chronic inflammation such as cancer and atherosclerosis.1,2

Prescription options—non-steroidal anti-inflammatory drugs (NSAIDs) andglucocorticoids—target only part of the overall chronic inflammatory response. Worse, they have substantial side effects and are not meant for long-term use.3,4

After combing through scores of nutrients, scientists have identified three compounds:curcumin, ginger, and turmeric oil that inhibit multiple underlying factors behind inflammation—safely reducing both chronic pain and long-term disease risk.

Numerous studies have confirmed that—by targeting the inflammatory origins—these natural extracts reduce the symptoms, risk profiles, and mediating factors of arthritis,5-12 cardiovascular disease,5,13-17 cancer,18-22 and other diseases…and some of these effects are observable in a matter of weeks!9,16,18,23

Even more exciting, scientists have discovered a novel way to deliver more of these three extracts to your bloodstream—almost seven times as much!24-27 These groundbreaking discoveries enhance the ability of these compounds to block the origins of chronic inflammation.

An All-Out Assault On Chronic Inflammation

When levels of certain cellular enzymes are increased, the result is chronic inflammation created by a complex “domino effect” of signaling molecules known as prostaglandins and leukotrienes.28-30 As scientists now know, the moreinflammation, particularly chronic inflammation, you have, the more rapidly your body ages.1

In fact, we know that almost all chronic diseases—from arthritis, to heart disease, to diabetes, to Alzheimer’s disease—have one thing in common: destructive, unchecked inflammation.31

Doctors have long known of individual compounds that can inhibit one of the steps involved in chronic inflammation, producing some anti-inflammatory response. For example, NSAIDs inhibit the production of prostaglandin signaling molecules by blocking enzymes known as COX-1 and COX-2. But they are not well characterized in terms of their ability to inhibit production of leukotriene signaling molecules, which requires blocking the LOX enzyme.32

Researchers sought natural compounds that could inhibit the multiple steps behind prostaglandin and leukotriene production to deliver broad-spectrum protection against chronic inflammation.

Unlike current medications, turmeric oil, ginger oil, and curcumin work through multiple mechanisms to block multiple pathways of the inflammation-signaling process.5,32-40

It makes sense that these extracts have similar anti-inflammatory effects—they belong to the same plant family, known asZingiberaceae.41

Turmeric Root Compounds  

Turmeric Root Compounds

Curcumin is packed with potent chemicals, collectively known as curcuminoids.42

Turmeric oil - the liquid produced during curcumin extraction43,44 - is rich in compounds known as aromatic turmerones.

Ginger Root Compounds

Ginger Root Compounds  

Ginger oil contains gingerolsshogaols, and sesquiterpenes, which are powerful anti-inflammatory active compounds.45

To illustrate a key element of their dramatically broader effectiveness against inflammation, these natural ingredients deliver a potent benefit that no currently available drug can—they block both COX and LOX enzymes, which in turn inhibits synthesis of both prostaglandin and leukotriene signaling molecules!32-40

This is of vital importance, because scientists have now discovered that agents that trigger dual inhibition of COX and LOX enzymes potentially provide “a better therapeutic profile” and produce almost no side effects compared to NSAIDs.32

Remarkably, when these three extracts are combined, they help prevent chronic inflammation by favorably modulating the activity of the following pathways. They:

  • Inhibit COX-1 and COX-2 enzymes;33-35
  • Inhibit LOX enzyme;36-38
  • Inhibit inducible nitric oxide (iNOS);33,36-38
  • Inhibit NF-kappaB;34,37,46
  • Inhibit degradation of IkappaB-alpha;46
  • Exert potent antioxidant activity —scavenging superoxide and hydroxyl radicals and reducing lipid peroxidation, early steps in the inflammation cascade,5,37 and inhibiting transcription of cell surface receptors for oxidized LDL cholesterol;47
  • Inhibit stimulated increase of prostaglandin E2 (PGE2).33

How these natural ingredients work at the cellular level may seem technical, but what you need to remember is that they are not synthetic drugs that are alien to your body’s systems. Instead, they work with your body’s own processes to help bring back natural function. Before we look at the many health benefits of these extracts, let’s learn how scientists have combinedall three—in a novel formulation that also delivers a further potent advantage: it naturally enhances absorption.

Enhanced-Absorption Formula

Curcumin has long been known to have poor bioavailability, requiring high doses to achieve desired blood levels.48-59 A new formulation solves this problem in two ways:

Instead of using standard curcumin, this formulation utilizes a curcumin extract that provides better bioavailability than ever thought possible. This “ next generation curcumin” is far more readily absorbed. Its potency is the synergy between the standard extracted curcuminoids plus the added-back, original turmeric compounds that are often removed in commercial processing. These novel, lipid-soluble active compounds called turmerones have been shown in human research to enhance curcumin absorption.27 In fact, two studies showed that it increases curcumin absorption almost 7-fold over a standard curcumin supplement.25,26

The second way this formulation boosts absorption is by including a special kind of molecule called phospholipids. They act as emulsifiers—agents that help oil molecules mix with water—and have been shown to enhance absorption of variousnutrients.60 A study confirmed that phospholipids boost curcumin absorption into intestinal cells.61

Let’s now examine some of the health benefits of curcumin, ginger, and turmeric that result from their ability to block themultiple pathways of deadly chronic inflammation.

WHAT YOU NEED TO KNOW
Blocking Chronic Inflammation

Blocking Chronic Inflammation

  • Millions of Americans endure the pain of chronic inflammation; even when pain is not apparent, millions more run the risk of serious diseases triggered by subclinical levels of chronic inflammation.
  • Mainstream medicine offers only drugs that typically target a single aspect of acute inflammatory pain, and that are typically not suitable for long-term use due to substantial side effects.
  • Researchers have found three natural ingredients that block inflammation at multiple stages of the process—inhibiting chronic inflammation at its root.
  • A wealth of clinical trials demonstrates that curcumin, ginger, and turmeric oil safely reduce both chronic pain and slash long-term disease risk, often in only a few weeks.
  • These three extracts have now been combined in a groundbreaking formulation that boosts absorption as much as 7-fold!

Cancer

Cancer is the second leading cause of death in the United States,62 and according to the American Cancer Society,63one of every three women in the US risks developing some form of cancer over the course of their lives. For men, that number rises to one in two. And inflammation is a major trigger.64

When normal inflammation continues over time and becomes prolonged or chronic, it can cause a multitude of pathologies—including cancers.63 Your body has a natural ability to fight cancer through the activity of tumor-suppressing genes. The science of epigenetics now indicates that both curcumin and gingerol (a key compound in ginger) can—in addition to inhibiting inflammation and modulating cell signaling pathways—reawaken these tumor-suppressing genes, turning them back on to block cancer!65,66

Over two thousand published studies have evaluated the effects of curcumin on many cancers—such as those of the breast, prostate, liver, skin, colon, and lung cancer20,67—by interfering at every stage of the complex sequence of their development, progression, and spread.68 While anticancer drugs often weaken the immune system, curcumin modulates it,68,69-78 serving as an “immune-restorer.”70

In just one of many curcumin studies on animals, scientists grafted human prostate-cancer cells onto special mice that subsequently developed tumors.79 The mice were fed curcumin or placebo five days weekly for four weeks. Afterward, curcumin-fed mice were divided into three groups: one continuing to receive curcumin alone, a second receiving curcumin plus the cancer chemotherapy drug, gemcitabine, and the third receiving curcumin plus radiation treatment.79

Curcumin inhibited cancer growth and enhanced antitumor effects of the drug and radiation. And in an exciting breakthrough, researchers traced these results to a newly discovered mechanism! They found that curcumin reduces expression of a molecule called MDM2—a gene that promotes cancer development, survival, and growth. This mechanism “may be essential for its chemopreventive and chemotherapeutic effects.”79

Ginger research on animals included a study in which scientists orally fed whole ginger extract to mice with prostate cancer. Ginger inhibited tumor growth and progression by 56%, with no detectable toxicity.80 In another study, the active ginger compound 6-gingerol suppressed growth of colorectal cancer cells and tumors in mice by inhibiting synthesis of the signaling molecule leukotriene A4.81

THE POWER OF THREE
The Power Of Three

Ginger (Zingiber officinale) and curcumin (Curcuma longa) are close botanical relatives. Both are rhizomes in the Zingiberaceae family.41 Because of observed “overlapping, but complementary, activities”115—scientists have increasingly focused on the therapeutic effects of combining these two plants.116

They found that “multiple mechanisms of protection against inflammation and oxidative damage make ginger and curcumin particularly promising natural agents in fighting the ravages of aging and degenerative diseases...”116

Turmeric oil is obtained from the potent liquid remaining after curcumin extraction.43,44Aside from turmeric oil’s own strong anti-inflammatory and antioxidant effects, research revealed that its rich content of compounds called aromatic turmerones massively enhances the absorption of curcumin.27 When turmeric oil was included, a human study demonstrated a 6.93-fold enhancement of bioavailability compared to normal curcumin.25

A newly developed formulation also boosts bioavailability—almost 7-fold—by using an advanced form of curcumin known as BCM-95® that includes lipid soluble active compounds called turmerones, which are normally left behind after curcumin extraction.25

This formulation also contains phospholipids, a type of emulsifying molecule that enhances absorption of poorly soluble active compounds.60,61

When turmeric oil was combined with curcumin in a novel complex, it enhanced bioavailability and completely abolished tumor formation in a mouse model of inflammation-associated colon carcinogenesis.82

These studies demonstrate that the three natural ingredients effectively block multiple pathways of cancer in animals. The real challenge, however, was whether these same plant extracts would be as effective in humans.

Curcumin was given to five patients with Crohn’s disease; an inflammatory condition associated with increased colorectal cancer risk.83 In all but one patient, both disease activity scores and sedimentation rates—a measure of inflammation—improved.84

In familial adenomatous polyposis (FAP), hundreds of colonic polyps form, some of which progress to colorectal cancer. Scientists gave five patients with familial adenomatous polyposis 480 milligrams of curcumin plus 20 milligrams of quercetinthree times daily for an average of six months. There was an average 51% decrease in the size of the polyps, and 60% decrease in the number of polyps.85 There was no noticeable toxicity.

Curcumin combined with either soy isoflavones or placebo was given to 85 men and those with high levels of prostate-specific antigen (PSA) were assessed separately. High PSA reflects inflammation and potential prostate cancer risk. After six months, PSA levels were significantly suppressed in the curcumin-isoflavones group.86

Ginger extract was given to one group of healthy volunteers in dosages of 2 grams daily, while others took placebo. On day 28, a colonic biopsy was taken on all participants. There was substantial reduction in average colonic mucosal levels of the inflammation signaling molecule prostaglandin E2 in the ginger subjects. They also had decreased average levels of an intermediate compound called 5-HETE, which is a potent survival factor that certain cancers use to escape destruction.18,125

Turmeric oil in dosages of 600 milligrams, mixed with 3 grams of turmeric extract, was given daily to patients with aggressive premalignant mouth lesions (oral submucous fibrosis), in a pilot study. Subjects showed a substantial decrease in the number of damaged, premalignant cells in both the mucous-membrane mouth lining and in circulating lymphocytes.19

HOW TO KNOW IF YOU HAVE CHRONIC INFLAMMATION
How To Know If You Have Chronic Inflammation

A growing consensus among scientists is that numerous common disorders are caused in part by chronic inflammation.31 For example, when inflammatory cytokines destroy joint cartilage and synovial fluid, arthritis results.92 If cytokines induce an autoimmune attack, they can trigger lupus.

The target of the chronic inflammatory response determines the disease risk. For instance, inflammation can result in brain cell damage and death (resulting in neurodegenerative disease), heart muscle wasting (contributing to congestive heart failure), or coronary atherosclerosis (potentially triggering a heart attack).117-119

Even obesity is related to chronic inflammation.120

Taking action to reduce chronic inflammation can dramatically minimize cellular aging and risk for lethal, age-relateddiseases.

Testing Inflammation Levels

So how do you know—before it’s too late—if your body is in a state of chronic inflammation?

Life Extension® long ago advised members to have an annual C-reactive protein blood test to detect potentially high levels of systemic inflammation that may be boosting your risk of a host of age-related diseases.31,121

If testing results show your C-reactive protein level is over 1.0 milligrams per liter (1.0 mg/L), this likely indicates that you have inflammatory activity occurring in your body and may be at increased risk for any number of serious medical conditions.122,123

Cardiovascular Disease

Inflammation plays a key role in the development of cardiovascular disease, which is responsible for almost one-in-four American deaths every year.87

Curcumin given to animals on a high-cholesterol diet decreased their total serum cholesterol 21% and their harmful low-density lipoprotein (LDL) by almost 43%, but increased their beneficial high-density lipoprotein (HDL) by 50%!15 Its lipid modulating effects have not been shown to work this well in humans.88

Ginger extract given to diabetic rats, significantly suppressed—in just seven weeks—cholesterol and triglycerides, high levels of which contribute to cardiovascular disease.16 It also significantly lowered blood sugar levels. In another study, ginger extract injected intravenously into rats was shown to significantly lower blood pressure and in a dose-dependent fashion.17

Stents that slowly release turmeric oil were implanted in dogs with blocked arteries. Scientists found that this turmeric-laced stent inhibited the infiltration of dangerous inflammatory cells. It also reduced various factors that often cause new arterial blockages to occur (restenosis).89

After these compelling findings, scientists turned their attention to human trials.

Given to clinical trial volunteers in dosages of 500 milligrams daily, curcumin showed a remarkable 29% increase in HDL cholesterol levels after just seven days.88 Even a one percent increase in this “good” form of cholesterol can reduce heart disease risk—so this finding is important.90

Ginger was shown to enhance efficacy of the antihypertensive drug nifedipine (Procardia®) in human subjects. Combiningone gram of ginger with 10 milligrams of the drug daily significantly boosted the anti-platelet aggregation effect in both normal and hypertensive persons.13 This is the tendency of blood cells to clump together, potentially producing a dangerous clot and pathological cardiovascular and cerebrovascular complications.

BLOCKING INFLAMMATION CAN PREVENT OBESITY AND DIABETES
Blocking Inflammation Can Prevent Obesity And Diabetes

In a study released June 18, 2013, ahead of print publication in the journal MolecularTherapy, scientists at the University of Georgia have demonstrated that blocking inflammation can prevent obesity and the early, obesity-related symptoms ofdiabetes.14

To block inflammation in test animals, researchers sometimes inject interleukin 10(IL10), an immune-regulating molecule naturally produced by the body to control inflammation.

In this experiment, two groups of mice were fed the same amounts of a high-fat diet. One group was also treated with injections of IL10.

While untreated mice fed a high-fat diet gained weight quickly and began to show the early symptoms of diabetes, those on the diet that were treated with IL10 maintained healthy fat levels and showed no signs of insulin resistance.124

This finding illustrates that lowering chronic inflammation levels in the body may inhibit two of the greatest epidemics of our time—obesity and diabetes—as well as the many other conditions associated with each of these diseases.

Arthritis

People over age 65 make up 65% of all American arthritis patients.91 The hallmarks of the most common form of this joint disease, osteoarthritis, are inflammation and cartilage destruction.92 Fortunately, while both ginger and curcumin block inflammation— curcumin also inhibits cartilage breakdown by the body!93 It does this by protecting the cells found in cartilage called chondrocytes from the inflammatory compounds (IL-1beta and MMP-3) that break them down in arthritis, as well as via other pathways.93

Curcumin strongly blocked rheumatoid arthritis symptoms in animal studies by inhibiting joint inflammation as effectively asmethotrexate,6 a drug with serious and sometimes fatal side effects.94 Curcumin improved arthritis scores in mice7 and suppressed osteoarthritis inflammation in dogs.95

Ginger extract blocked inflammatory mediators in a cell culture study—notably the signaling molecule prostaglandin E2—and reduced inflammatory swelling (edema). Researchers described the results as, “a potent suppressive effect on acute and chronic inflammation.”11

Clinical trials have now confirmed these results in humans.

Curcumin in doses of 500 milligrams daily was given to one group of rheumatoid arthritis patients. The NSAID drugdiclofenac in doses of 50 milligrams daily was given to a second group. And a combination of the two was given to a third group. The group receiving curcumin-only had the greatest reduction in joint pain and swelling, with no adverse effects. By contrast, nearly 14% of participants in the drug-only group dropped out due to adverse effects!8

Ginger or placebo was given to 29 patients with symptomatic knee arthritis in dosages of four daily capsules of 250milligrams each. After three months, those taking placebo switched to ginger and those taking ginger switched to placebo, and then the study continued for an additional three months. After a total of six months, the patients experienced significantly less pain and handicap during their ginger-supplemented months than during their placebo months—and reported improvements on a standardized scale used to assess mobility.12

Also, ginger extract given to osteoarthritis patients in doses of 340 milligrams daily for 4 weeks proved equally as effective as 100 milligrams of the drug diclofenac.However, the drug group experienced an increase in digestive pain (dyspepsia) and degeneration of their stomach mucosa.9

Diabetes

Among Americans 65 or over, 26.9% have diabetes.96 Diabetics are at risk for pain associated with nerve damage (neuropathic pain),97 accelerated brain aging and cognitive decline (diabetic encephalopathy)98,99 and, of course, high blood sugar. However, the powerful plant extracts we’ve been discussing have the potential to prevent or reverse many of these complications.

Curcumin successfully attenuated experimentally-induced neuropathic pain response—recognized as one of the most difficult types of pain to treat—to mild stimuli (hyperalgesia) in diabetic rats.100 This powerful action is likely due to curcumin’s ability to reduce inflammation signaling molecules called cytokines, reduce the activation of pain signaling molecules and receptors, and reduce the depressive effect of pain.101-107 Also, chronic curcumin treatment reversed much of the extreme inflammation and oxidation damage in the brains of diabetic rats and substantially boosted their performance on memory and cognition tasks.99

Ginger extract was given to diabetic rats, and after just seven weeks, their fasting glucose levels —the blood sugar reading between meals — were significantly reduced.16 The researchers suggested that “ginger may be of great value in managing the effects of diabetic complications of diabetes in human subjects.”16

Dementia

Memory and cognitive decline often starts about age 50, and by age 80, it is estimated nearly half of all individuals will have some form of cognitive change or dementia.108 As you’ll see, curcumin and ginger offer great promise to stave off this tragedy.

Curcumin administered in animal models of Alzheimer’s has been shown to enhance clearance of amyloid-beta from the brain. This is a malformed protein, the accumulation of which is strongly associated with Alzheimer’s. Curcumin crosses the blood-brain barrier and appears to directly bind to the plaque!109

Scientists fed ginger extract to rats for two weeks before they blocked (occluded) an artery in the brain, and for three weeks afterward. Cognitive testing was done at the end of each of the three weeks following arterial blockage. Researchers found that the ginger extract significantly increased cognitive function and neuron density (in the brain area known as the hippocampus) while significantly decreasing the area of damaged brain tissue—or brain infarct.110

A study team incubated curcumin with macrophages (immune cells) taken from human Alzheimer’s patients. These macrophages are immune cells that normally identify, engulf, and destroy amyloid-beta, but in Alzheimer’s patients these macrophages failed to handle this function.111 In the laboratory, after being treated with curcumin, macrophages from half of the patients significantly increased the amount of amyloid-beta they were able to absorb (uptake).112 These data demonstrate that curcumin may be able to defend against—and even reverse—the Alzheimer’s disease process.

Ginger was tested in a study of 60 healthy middle-aged women who were given 400 or 800 milligrams of the extract, or placebo, daily for two months. Their working memory and cognition were tested before supplementation and after one and two months. The ginger participants showed significantly enhanced working memory, and brain activity consistent with boosted cognitive capability. This suggests that ginger may defend against, and reverse middle-aged cognitive function.113

Turmeric oil was found to exhibit powerful and broad antioxidant activity,and data suggest it may suppress neuroinflammation in neurodegenerative diseases, including Alzheimer’s.46,114

Summary

Even when pain is not initially apparent, chronic inflammation can eventually lead to serious diseases such as cancer.1,2

Drugs that target acute inflammation are often not suitable for long-term use, and may involve substantial side effects.3,4

In a significant breakthrough, three natural ingredients have been identified that powerfully block the signaling molecules that trigger chronic inflammation.5,32-40

Ginger , curcumin, and turmeric oil block inflammation at multiple points of the process, safely minimizing long-term disease risk.5,32-40

Multiple studies demonstrate that these three extracts combat an array of disorders, including cancer, cardiovascular disease, and arthritis.5-22

These three extracts have been combined in a groundbreaking formulation that greatly boosts absorption!25,27,60,61

References

  1. Strzelecka M, Bzowska M, Kozieł J, et al. Anti-inflammatory effects of extracts from some traditional Mediterranean diet plants. J Physiol Pharmacol. 2005 Mar;56 Suppl 1:139-56.
  2. Ramos-Nino ME. The role of chronic inflammation in obesity-associated cancers. ISRN Oncol. 2013 May 30;2013:697521.
  3. Peterson K, McDonagh M, Thakurta S, et al. Drug Class Review: Nonsteroidal Antiinflammatory Drugs (NSAIDs): Final Update 4 Report. National Institute of Health (NIH) PubMed Health. Bethesda (MD): National Library of Medicine (US). Nov 2010.
  4. Dixon WG, Bansback N. Understanding the side effects of glucocorticoid therapy: shining a light on a drug everyone thinks they know. Ann Rheum Dis . 2012 Nov;71(11):1761-4.
  5. Liju VB, Jeena K, Kuttan R. An evaluation of antioxidant, anti-inflammatory, and antinociceptive activities of essential oil from Curcuma longa. L. Indian J Pharmacol. 2011 Sep;43(5):526-31.
  6. Jancinova V, Perecko T, Nosal R, Kostalova D, Bauerova K, Drabikova K. Decreased activity of neutrophils in the presence of diferuloylmethane (curcumin) involves protein kinase C inhibition. Eur J Pharmacol. 2009 Jun 10;612(1-3):161-6.
  7. Moon DO, Kim MO, Choi YH, Park YM, Kim GY. Curcumin attenuates inflammatory response in IL-1beta-induced human synovial fibroblasts and collagen-induced arthritis in mouse model. Int Immunopharmacol. 2010 May;10(5):605-10.
  8. Chandran B, Goel A. A randomized, pilot study to assess the efficacy and safety of curcumin in patients with active rheumatoid arthritis. Phytother Res. 2012 Nov;26(11):1719-25.
  9. Drozdov VN, Kim VA, Tkachenko EV, Varvanina GG. Influence of a specific ginger combination on gastropathy conditions in patients with osteoarthritis of the knee or hip. J Altern Complement Med. 2012 Jun;18(6):583-8.
  10. Srivastava KC, Mustafa T. Ginger (Zingiber officinale) in rheumatism and musculoskeletal disorders. Med Hypotheses. 1992 Dec;39(4):342-8.
  11. Shimoda H, Shan SJ, Tanaka J, et al. Anti-inflammatory properties of red ginger (Zingiber officinale var. Rubra) extract and suppression of nitric oxide production by its constituents. J Med Food. 2010 Feb;13(1):156-62.
  12. Wigler I, Grotto I, Caspi D, Yaron M. The effects of Zintona EC (a ginger extract) on symptomatic gonarthritis. Osteoarth Cartilage. 2003 Nov;11(11):783-9.
  13. Young HY, Liao JC, Chang YS, Luo YL, Lu MC, Peng WH. Synergistic effect of ginger and nifedipine on human platelet aggregation: a study in hypertensive patients and normal volunteers. Am J Chin Med. 2006;34(4):545-51.
  14. Li HL, Liu C, de Couto G, et al. Curcumin prevents and reverses murine cardiac hypertrophy. J Clin Invest. 2008 Mar;118(3):879-93.
  15. Arafa HM. Curcumin attenuates diet-induced hypercholesterolemia in rats. Med Sci Monit. 2005 Jul;11(7):BR228-34.
  16. Al-Amin ZM, Thomson M, Al-Qattan KK, Peltonen-Shalaby R, Ali M. Anti-diabetic and hypolipidaemic properties of ginger (Zingiber officinale) in streptozotocin-induced diabetic rats. Br J Nutr. 2006 Oct;96(4):660-6.
  17. Ghayur MN, Gilani AH. Ginger lowers blood pressure through blockade of voltage-dependent calcium channels. J Cardiovasc Pharmacol. January 2005; 45(1):74-80.
  18. Zick SM, Turgeon DK, Vareed SK, et al. Phase II study of the effects of ginger root extract on eicosanoids in colon mucosa in people at normal risk for colorectal cancer. Cancer Prev Res (Phila). 2011 Nov;4(11):1929-37.
  19. Hastak K, Lubri N, Jakhi SD, et al. Effect of turmeric oil and turmeric oleoresin on cytogenetic damage in patients suffering from oral submucous fibrosis. Cancer Lett. 1997 Jun 24;116(2):265-9.
  20. Shehzad A, Wahid F, Lee YS. Curcumin in cancer chemoprevention: molecular targets, pharmacokinetics, bioavailability, and clinical trials. Arch Pharm (Weinheim). 2010;343(9):489-99.
  21. Kunnumakkara AB, Anand P, Aggarwal BB. Curcumin inhibits proliferation, invasion, angiogenesis and metastasis of different cancers through interaction with multiple cell signaling proteins. Cancer Lett. 2008 Oct 8;269(2):199-225.
  22. Baliga MS, Haniadka R, Pereira MM, et al. Update on the chemopreventive effects of ginger and its phytochemicals. Crit Rev Food Sci Nutr. 2011 Jul;51(6):499-523.
  23. DiSilvestro RA, Joseph E, Zhao S, Bomser J. Diverse effects of a low dose supplement of lipidated curcumin in healthy middle aged people. Nutr J. 2012;11:79.
  24. Available at: http://www.ajofai.info/Abstract/(6)-gingerol%20content%20and%20bioactive%20properties%20of%20ginger%20(zingiber%20officinale%20roscoe) %20extracts%20from%20supercritical%20co2%20extraction.pdf. Accessed August 23, 2013.
  25. Antony B, Merina B, Iyer VS, Judy N, Lennertz K, Joyal S. A pilot cross-over study to evaluate human oral bioavailability of BCM-95CG (Biocurcumax), A novel bioenhanced preparation of curcumin. Indian J Pharm Sci. 2008 Jul-Aug;70(4):445-9.
  26. Benny M, Antony B. Bioavailability of Biocurcumax (BCM-095™). Spice India. 2006 Sept 9;19(9):11-5.
  27. Yue GG, Cheng SW, Yu H, et al. The role of turmerones on curcumin transportation and P-glycoprotein activities in intestinal Caco-2 cells. J Med Food. 2012 Mar;15(3):242-52.
  28. Singh VP, Patil CS, Kulkarni SK. Differential effect of zileuton, a 5-lipoxygenase inhibitor, against nociceptive paradigms in mice and rats. Pharmacol Biochem Behav. 2005 Jul;81(3):433-9.
  29. Gregus AM, Doolen S, Dumlao DS, et al. Spinal 12-lipoxygenase-derived hepoxilin A3 contributes to inflammatory hyperalgesia via activation of TRPV1 and TRPA1 receptors. Proc Natl Acad Sci U S A. 2012 Apr 24;109(17):6721-6.
  30. Seybold VS, Jia YP, Abrahams LG. Cyclo-oxygenase-2 contributes to central sensitization in rats with peripheral inflammation. Pain. 2003 Sep;105(1-2):47-55.
  31. Chung HY, Cesari M, Anton S, et al. Molecular inflammation: underpinnings of aging and age-related diseases. Ageing Res Rev. 2009 Jan;8(1):18-30.
  32. Grzanna R, Lindmark L, Frondoza CG. Ginger—an herbal medicinal product with broad anti-inflammatory actions. J Med Food. 2005 Summer;8(2):125-32.
  33. Li F, Nitteranon V, Tang X, et al. In vitro antioxidant and anti-inflammatory activities of 1-dehydro-[6]-gingerdione, 6-shogaol, 6-dehydroshogaol and hexahydrocurcumin. Food Chem. 2012 Nov 15;135(2):332-7.
  34. Cretu E, Trifan A, Vasincu A, Miron A. Plant-derived anticancer agents - curcumin in cancer prevention and treatment.Rev Med Chir Soc Med Nat Iasi. 2012 Oct-Dec;116(4):1223-9.
  35. Plummer SM, Hill KA, Festing MF, Steward WP, Gescher AJ, Sharma RA. Clinical development of leukocyte cyclooxygenase 2 activity as a systemic biomarker for cancer chemopreventive agents. Cancer Epidemiol Biomarkers Prev. 2001 Dec;10(12):1295-9.
  36. Menon VP, Sudheer AR. Antioxidant and anti-inflammatory properties of curcumin. Adv Exp Med Biol. 2007;595:105-25.
  37. Baliga MS, Joseph N, Venkataranganna MV, Saxena A, Ponemone V, Fayad R. Curcumin, an active component of turmeric in the prevention and treatment of ulcerative colitis: preclinical and clinical observations. Food Funct. 2012 Nov;3(11):1109-17.
  38. Tsai KD, Lin JC, Yang SM, et al. Curcumin Protects against UVB-Induced Skin Cancers in SKH-1 Hairless Mouse: Analysis of Early Molecular Markers in Carcinogenesis. Evid Based Complement Alternat Med. 2012;2012:593952.
  39. Flynn DL, Rafferty MF, Boctor AM. Inhibition of 5-hydroxy-eicosatetraenoic acid (5-HETE) formation in intact human neutrophils by naturally-occurring diarylheptanoids: inhibitory activities of curcuminoids and yakuchinones.Prostaglandins Leukot Med. 1986 Jun; 22(3):357-60.
  40. Kiuchi F, Iwakami S, Shibuya M, Hanaoka F, Sankawa U. Inhibition of prostaglandin and leukotriene biosynthesis by gingerols and diarylheptanoids. Chem Pharm Bull (Tokyo). 1992 Feb; 40(2):387-91.
  41. Available at: http://www.botany.hawaii.edu/faculty/carr/zingiber.htm. Accessed November 12, 2013.
  42. Verma MK, Najar IA, Tikoo MK, et al. Development of a validated UPLC-qTOF-MS Method for the determination of curcuminoids and their pharmacokinetic study in mice. Daru. 2013 Jan 29;21(1):11.
  43. Negi PS, Jayaprakasha GK, Jagan Mohan Rao L, Sakariah KK. Antibacterial activity of turmeric oil: a byproduct from curcumin manufacture. J Agric Food Chem. 1999 Oct;47(10):4297-300.
  44. Jayaprakasha GK, Negi PS, Anandharamakrishnan C, Sakariah KK. Chemical composition of turmeric oil--a byproduct from turmeric oleoresin industry and its inhibitory activity against different fungi. Z Naturforsch C. 2001 Jan-Feb;56(1-2):40-4.
  45. Butt MS, Sultan MT. Ginger and its health claims: molecular aspects. Crit Rev Food Sci Nutr. 2011 May;51(5):383-93.
  46. Park SY, Jin ML, Kim YH, Kim Y, Lee SJ. Anti-inflammatory effects of aromatic-turmerone through blocking of NF-kappaB, JNK, and p38 MAPK signaling pathways in amyloid beta-stimulated microglia. Int Immunopharmacol. 2012 Sep;14(1):13-20.
  47. Lee HS, Lee MJ, Kim H, et al. Curcumin inhibits TNFalpha-induced lectin-like oxidised LDL receptor-1 (LOX-1) expression and suppresses the inflammatory response in human umbilical vein endothelial cells (HUVECs) by an antioxidant mechanism. J Enzyme Inhib Med Chem. 2010 Oct;25(5):720-9.
  48. Wahlstrom B, Blennow G. A study on the fate of curcumin in the rat. Acta Pharmacol Toxicol (Copenh). 1978;43:86-92.
  49. Ravindranath V, Chandrasekhara N. In vitro studies on the intestinal absorption of curcumin in rats. Toxicology. 1981;20:251-7.
  50. Holder GM, Plummer JL, Ryan AJ. The metabolism and excretion of curcumin (1,7-bis-(4-hydroxy-3-methoxyphenyl)-1,6-heptadiene-3,5-dione) in the rat. Xenobiotica. 1978;8:761-8.
  51. Ravindranath V, Chandrasekhara N. Metabolism of curcumin—studies with [3H] curcumin. Toxicology. 1982;22:337-44.
  52. Ravindranath V, Chandrasekhara N. Absorption and tissue distribution of curcumin in rats. Toxicology. 1980;16:259-65.
  53. Pan MH, Huang TM, Lin JK. Biotransformation of curcumin through reduction and glucuronidation in mice. Drug Metab Disp. 1999;27:486-94.
  54. Ireson C, Orr S, Jones DJ, et al. Characterization of metabolites of the chemopreventive agent curcumin in human and rat hepatocytes and in the rat In Vivo, and evaluation of their ability to inhibit phorbol ester-induced prostaglandin E2 production. Cancer Res. 2001;61:1058-64.
  55. Ireson CR, Jones DJ, Orr S, Coughtrie MW, Boocock DJ, Williams ML, et al. Metabolism of the cancer preventive agent curcumin in human and rat intestine. Cancer Epidemiol Biomarkers Prev. 2002;11:105-11.
  56. Hoehle SI, Pfeiffer E, Solyom AM, Metzler M. Metabolism of curcuminoids in tissue slices and subcellular fractions from rat liver. J Agr Food Chem . 2006;54:756-64.
  57. Sharma RA, McLelland HR, Hill KA, et al. Pharmacodynamic and pharmacokinetic study of oral Curcuma extract in patients with colorectal cancer. Clin Cancer Res. 2001;7:1894-900.
  58. Garcea G, Berry DP, Jones DJ. Consumption of the putative chemopreventive agent curcumin by cancer patients: Assessment of curcumin levels in the colorectum and their pharmacodynamic consequences. Cancer Epidemiol Biomarkers Prev. 2005;14:120-5.
  59. Sharma RA, Euden SA, Platton SL, et al. Phase I clinical trial of oral curcumin: Biomarkers of systemic activity and compliance. Clin Cancer Res. 2004;10:6847-54.
  60. Available at: http://www.ijbpr.com/admin/fckeditor/_samples/php/article/250_946-955.pdf. Accessed November 12, 2013.
  61. Marczylo TH. Verschoyle RD. Cooke DN. Morazzoni P. Steward WP. Gescher AJ. Comparison of systemic availability of curcumin with that of curcumin formulated with phosphatidylcholine. Cancer Chemother Pharmacol. 2007;60:171-7.
  62. Subramaniam D, Ramalingam S, Houchen CW, Anant S. Cancer stem cells: a novel paradigm for cancer prevention and treatment. Mini Rev Med Chem. 2010 May;10(5):359-71.
  63. Available at: http://seer.cancer.gov/statfacts/html/all.html. Accessed November 12, 2013.
  64. Vendramini-Costa DB, Carvalho JE. Molecular link mechanisms between inflammation and cancer. Curr Pharm Des. 2012;18(26):3831-52.
  65. Meeran SM, Ahmed A, Tollefsbol TO. Epigenetic targets of bioactive dietary components for cancer prevention and therapy. Clin Epigenetics. 2010;1(3-4):101-6.
  66. Anand P, Sundaram C, Jhurani S, Kunnumakkara AB, Aggarwal BB. Curcumin and cancer: an “old-age” disease with an “age-old” solution. Cancer Lett. 2008 Aug 18;267(1):133-64.
  67. Johnson JJ, Mukhtar H. Curcumin for chemoprevention of colon cancer. Cancer Lett. 2007;255(2):170-81.
  68. Thangapazham RL, Sharma A, Maheshwari RK. Multiple molecular targets in cancer chemoprevention by curcumin.AAPS J. 2006;8(3):E443-9.
  69. Jagetia GC, Aggarwal BB. “Spicing up” of the immune system by curcumin. J Clin Immunol. 2007 Jan;27(1):19-35.
  70. Bhattacharyya S, Mandal D, Sen GS, et al. Tumor-induced oxidative stress perturbs nuclear factor-kappaB activity-augmenting tumor necrosis factor-alpha-mediated T-cell death: protection by curcumin. Cancer Res. 2007 Jan 1;67(1):362-70.
  71. Churchill M, Chadburn A, Bilinski RT, Bertagnolli MM. Inhibition of intestinal tumors by curcumin is associated with changes in the intestinal immune cell profile. J Surg Res. 2000 Apr;89(2):169-75.
  72. Pal S, Bhattacharyya S, Choudhuri T, et al. Amelioration of immune cell number depletion and potentiation of depressed detoxification system of tumor-bearing mice by curcumin. Cancer Detect Prev. 2005;29(5):470-8.
  73. Perkins S, Verschoyle RD, Hill K, et al. Chemopreventive efficacy and pharmacokinetics of curcumin in the min/+ mouse, a model of familial adenomatous polyposis. Cancer Epidemiol Biomarkers Prev. 2002 Jun;11(6):535-40.
  74. South EH, Exon JH, Hendrix K. Dietary curcumin enhances antibody response in rats. Immunopharmacol Immunotoxicol. 1997 Feb;19(1):105-19.
  75. Kurup VP, Barrios CS, Raju R, et al. Immune

Skriv din egen omtale

Only registered users can write reviews. Please, log in or register

Produkttagger

Bruk mellomrom for å skille tagger. Omgi setninger med apostrof (').

Tilleggsinfo

ProdusentNei
MomsklasseMomspliktige varer 15%

Dette er en erstatning for salgsproduktene